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Group B streptococcus (GBS) neonatal invasive infections in 
Belgium, 2013-2016. 
BACKGROUND & OBJECTIVES 
Epidemiology, clinical and biological characteristics
Since 2003, intrapartum antimicrobial prophylaxis (IAP)
based on a universal screening for GBS colonization at 35-
37 weeks’ gestation is recommended in Belgium: a
decrease of the incidence of GBS early onset disease (EOD)
among newborns was observed whereas incidence of GBS
late onset disease (LOD) has remained unchanged.
The Belgian National Reference Centre (NRC) routinely
performs surveillances of GBS invasive strains.
This study refers to GBS neonatal invasive diseases
reported to the Belgian NRC from 2013 to mid-2016.
• To provide clinical and some demographic description
of GBS EOD and LOD cases
• To report the distribution of capsular types of GBS
causing neonatal EOD and LOD.










§ CPS	type	III	predominated	in	neonatal	infections	;	CPS	type	Ia,	II	and	V	are	2nd and	3rd rank	for	EOD.
§ Antenatal	screening	was	not	totally	universal	in	mothers	of	cases;	predictive	values	were	not	worst	than	expected	but	only	60%	of	
known	positive	mothers	of	EOD	case	get	an	IAP.	




• Overall through 2013 to mid-2016, on a voluntary base, laboratories belonging to the national surveillance network sent
to the NRC a total of 157 GBS strains isolated from bloodculture or cerebro-spinal fluid of newborns with invasive
disease.








Table1 : Overview of the main clinical and biological characteristics of GBS EOD and LOD 
cases in Belgium, through 2013 to mid-2016.
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Figure 1: Distribution of 
CPS types of 137 GBS strains 
isolated from newborns with 
invasive disease: 70 EOD 
and 67 LOD. 
(Y axis: number of cases)
• A total of 157 GBS neonatal invasive diseases were reported to the NRC GBS and all the
corresponding isolates were also sent to the NRC GBS.
• A minimum of data were available for 137 cases. According to age at onset there were 70
(51%) EOD and 67 (48.9%) LOD cases
• Considering the incidence of GBS neonatal infections in Belgium, this collection represented
about 40% of GBS invasive diseases.






Age	at	onset	(day) 0	(0-1) 28	(16.5-45.5) <	0.001
Birth	weight	(g) 3,320	(3,047-3,657) 3,080	(1,850-3,455) 0.096
Gestational	age	(weeks) 39	4/7	(38-40	4/7) 38	(33	1/7-39.6	6/7) 0.009
Birth	in	twins	(%) 3.5 15 NS
Sex	M/F 1.33 1.16 NS



























Neonatal	Intensive	care 32.1% 37.5% NS












Distribution of CPS types among GBS isolated from 






























Table2: Overview of risk factors for GBS EOD and LOD cases in Belgium, through 2013 to 
mid-2016.
